Public Comment Sought on Draft Statement on Ovarian Cancer ScreeningThe U.S. Preventive Services Task Force (USPSTF) issued a draft statement reaffirming its recommendation against routine screening for ovarian cancer in women who are at average risk of the disease. The draft Reaffirmation Recommendation Statement is available for comment until May 8 at 5:00 p.m. ET.
Based on an evidence review published April 10, the USPSTF concluded that routine screening with transvaginal ultrasound and testing for the serum tumor marker CA-125 does not help to reduce deaths from ovarian cancer. "There is at least moderate certainty that the harms of screening for ovarian cancer outweigh the benefits," the draft states.
Instructions on how to submit comments are available online .
See also: "Ovarian Cancer Screening Method Fails to Reduce Deaths from the Disease"